OptimizeRx
OPRX
163 hedge funds and large institutions have $1.19B invested in OptimizeRx in 2021 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 51 increasing their positions, 53 reducing their positions, and 21 closing their positions.
100% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 21
71% more funds holding in top 10
Funds holding in top 10: 7 → 12 (+5)
56% more capital invested
Capital invested by funds: $760M → $1.19B (+$426M)
24% more call options, than puts
Call options by funds: $98.5M | Put options by funds: $79.2M
15% more funds holding
Funds holding: 142 → 163 (+21)
7.63% more ownership
Funds ownership: 71.14% → 78.77% (+7.6%)
4% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 53
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$36.9M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$24M |
| 3 |
BCH
Berkshire Capital Holdings
San Jose,
California
|
+$23.8M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$22M |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$14.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$9.88M |
| 2 |
AC
Avenir Corporation
Alexandria,
Virginia
|
-$8.13M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$7.44M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$6.54M |
| 5 |
Handelsbanken Fonder
Stockholm,
Sweden
|
-$6.27M |
OPRX Hedge Fund Activity: Q3 2021 in Review
163 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q3 2021, worth a combined $1.19B — up 56% from $760M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new OPRX positions and 21 closed out — a net gain of 21 holders — while 51 added to existing stakes and 53 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $36.9M. The largest seller was First Light Asset Management, cutting an estimated $9.88M.
- 163 institutional investors held OptimizeRx (OPRX) as of Q3 2021, up from 142 in Q2 2021.
- Funds reported $1.19B of OptimizeRx stock for Q3 2021, up 56% quarter-over-quarter.
- 42 funds opened new OptimizeRx positions in Q3 2021 and 21 closed out, a net change of +21 holders.
- The largest OptimizeRx buyer in Q3 2021 was Millennium Management, an estimated $36.9M added.
- The largest OptimizeRx seller in Q3 2021 was First Light Asset Management, an estimated $9.88M sold.
Based on aggregated 13F filings for Q3 2021.